R. Hulhoven

发表

Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.

W. Bridson, D. Rosillon, A. Stockis, 2008, Clinical therapeutics.

Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic

P. Hermann, J. Desager, C. Harvengt, 1988, Psychopharmacology.

Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study

D. Rosillon, A. Stockis, R. Hulhoven, 2007, European Journal of Clinical Pharmacology.

Clinical trials with daunorubincin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma

A. Ferrant, J. Michaux, G. Sokal, 2004, Cancer Chemotherapy and Pharmacology.

Uricosuric Effect of Fenofibrate in Healthy Volunteers

J. Desager, C. Harvengt, R. Hulhoven, 1980, Journal of clinical pharmacology.

Beta-blocking agents and plasma lipids: an update.

J. Desager, C. Harvengt, F. Heller, 1987, Advances in experimental medicine and biology.

Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.

N. Cranswick, R. Hulhoven, J. Turzíková, 2005, International journal of clinical pharmacology and therapeutics.

Quantitative determination of low levels of daunomycin and daunomycinol in plasma by high-performance liquid chromatography.

J. Desager, R. Hulhoven, 1976, Journal of chromatography.

CETIRIZINE IN POLLEN-ASSOCIATED ASTHMA

R. Hulhoven, A. Kurzeja, B. Riedelsheimer, 1989, The Lancet.

Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation.

J. Squifflet, J. Jamart, J. Ketelslegers, 1995, Clinical transplantation.

Daunorubicin, daunorubicinol and DNA plasma kinetics after I.V. administration of daunorubicin-DNA complex in the rabbit. II. -- Effects of R. E. S.-blockade.

R. Hulhoven, C. Haravengt, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Vindesine and Prednisone in the Treatment of Relapsed Lymphomalignancies, Blastic Crisis of Chronic Myelocytic Leukemia and Acute Myelomonocytic Leukemia

A. Delannoy, A. Ferrant, G. Sokal, 1981 .

A phase II study of vindesine in patients with hematological malignancies.

A. Delannoy, A. Ferrant, J. Michaux, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Plasma kinetics of mitoxantrone in leukemic patients

C. Harvengt, E. Dumont, R. Hulhoven, 1984, Medical oncology and tumor pharmacotherapy.

Acute cardiovascular and renal changes induced by mitoxantrone in rabbits. A pharmacokinetic approach.

C. Harvengt, E. Dumont, R. Hulhoven, 1983, Toxicology letters.

Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjects

J. Desager, C. Harvengt, R. Hulhoven, 2004, European Journal of Clinical Pharmacology.

Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.

H. Tapiero, J. Misset, D. Machover, 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effect of brivaracetam on cardiac repolarisation – a thorough QT study*

D. Rosillon, R. Hulhoven, M. Meeus, 2008, Current medical research and opinion.

Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers

M. Longueville, J. Desager, C. Harvengt, 1997, Clinical pharmacology and therapeutics.

LACK OF CLINICALLY RELEVANT INTERACTION OF CETIRIZINE ON THEOPHYLLINE DISPOSITION IN HEALTHY SUBJECTS: A PLACEBO‐CONTROLLED STUDY

J. Desager, C. Harvengt, R. Hulhoven, 1995, American journal of therapeutics.

Single‐Dose Pharmacokinetics of Cetirizine in Patients With Chronic Liver Disease

Y. Horsmans, C. Harvengt, R. Hulhoven, 1993, Journal of clinical pharmacology.

Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.

J. Desager, C. Harvengt, R. Hulhoven, 1985, International journal of clinical pharmacology, therapy, and toxicology.

Lack of interaction between zolpidem and H2 antagonists, cimetidine and ranitidine.

P. Hermann, J. Desager, C. Harvengt, 1988, International journal of clinical pharmacology research.

Daunorubicin-DNA complex in acute nonlymphoblastic leukemia

C. Peterson, C. Harvengt, R. Hulhoven, 2004, Cancer Chemotherapy and Pharmacology.

Distribution of daunorubicin intravenously injected or intravenously infused as free drug and as a complex with DNA in rabbits.

C. Harvengt, R. Hulhoven, 1982, Pharmacology.

Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.

H. Tapiero, J. Misset, D. Machover, 1984, Cancer treatment reports.

Levetiracetam and bleeding disorders.

P. Boon, F. Offner, R. Hulhoven, 2007, Acta neurologica Belgica.

Phase I‐II study of aclarubicin for treatment of acute myeloid leukaemia

F. Vassal, H. Tapiero, J. Misset, 1987, European journal of haematology. Supplementum.

Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.

W. Bridson, D. Rosillon, A. Stockis, 2008, Clinical therapeutics.

Plasma levels and biotransformation of infused daunorubicin and daunorubicin-DNA complex in rabbits: a preliminary report.

J. Desager, C. Harvengt, R. Hulhoven, 1977, European journal of cancer.